Mark Olsen

Mark Olsen Email and Phone Number

Chief Executive Officer and Founder @ Crenae Therapeutics
Phoenix, AZ, US
Mark Olsen's Location
Phoenix, Arizona, United States, United States
Mark Olsen's Contact Details

Mark Olsen personal email

n/a
About Mark Olsen

Inventor of aspartyl(asparaginyl)-beta-hydroxylase (ASPH) inhibitor chemotypes for the treatment of hepatocellular carcinoma and other cancers. Interested in the design and synthesis of iron-dependent dioxygenase inhibitors, including the enzymes FTO, TET1-3, PHD1-3, FIH, and OGFOD. ASPH inhibitors have been designed, tested, and patented as described in PCT/US2013/061050, which is available for licensing.

Mark Olsen's Current Company Details
Crenae Therapeutics

Crenae Therapeutics

View
Chief Executive Officer and Founder
Phoenix, AZ, US
Website:
lbgfinanciallc.godaddysites.com
Employees:
37
Mark Olsen Work Experience Details
  • Crenae Therapeutics
    Chief Executive Officer And Founder
    Crenae Therapeutics
    Phoenix, Az, Us
    View
  • Crenae Therapeutics
    Chief Executive Officer And Founder
    Crenae Therapeutics Feb 2020 - Present
    Phoenix, Arizona, United States
    Crenae Therapeutics is a company developing next generation antimetastatic therapeutics for the treatment of cancer.
    View
  • Midwestern University
    Associate Professor
    Midwestern University Dec 2008 - Present
    Design and synthesis of 2-oxoglutarate mimics
    View
  • West Texas A&M University
    Assistant Professor
    West Texas A&M University Apr 2004 - Jan 2009
    Directed evolution of chondroitin lyases
    View
  • The University Of Texas At Austin
    Graduate Student (Phd)
    The University Of Texas At Austin 1994 - 2002

Mark Olsen Skills

Antibodies Biochemistry High Throughput Screening Molecular Biology Life Sciences Science Flow Cytometry Protein Purification Cell Biology Organic Synthesis Directed Evolution Protein Chemistry Public Speaking Clinical Research Healthcare Pharmaceutical Industry Medicinal Chemistry

Mark Olsen Education Details

Frequently Asked Questions about Mark Olsen

What company does Mark Olsen work for?

Mark Olsen works for Crenae Therapeutics

What is Mark Olsen's role at the current company?

Mark Olsen's current role is Chief Executive Officer and Founder.

What is Mark Olsen's email address?

Mark Olsen's email address is mo****@****ern.edu

What schools did Mark Olsen attend?

Mark Olsen attended Massachusetts Institute Of Technology, The University Of Texas At Austin, University Of Wisconsin-Madison, The Ohio State University.

What skills is Mark Olsen known for?

Mark Olsen has skills like Antibodies, Biochemistry, High Throughput Screening, Molecular Biology, Life Sciences, Science, Flow Cytometry, Protein Purification, Cell Biology, Organic Synthesis, Directed Evolution, Protein Chemistry.

Not the Mark Olsen you were looking for?

  • Mark Olsen

    Mark Olsen
    Grapevine, Tx
  • Mark Olsen

    Mark Olsen
    Executive Director At Jp Morgan Private Bank
    Atlanta, Ga
    4
    gmail.com, jpmchase.com, jpmorgan.com, jpmorgan.com
  • Mark Olsen

    Mark Olsen
    San Francisco, Ca
    7
    gmail.com, yahoo.com, snet.net, snet.net, stericycle.com, stericycle.com, modsquad.com

    5 +141551XXXXX

  • Mark Olsen

    Mark Olsen
    Chief Manufacturing And Supply Chain Officer
    Bedford, Ma
    5
    aol.com, ilww.com, instrumentationlaboratory.com, ilww.com, werfen.com

    2 +178167XXXXX

  • Mark Olsen

    Mark Olsen
    Bedford, Nh
    1
    yahoo.com

    1 +160371XXXXX

View similar profiles

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.